C. Caracò

发表

Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy

P. Ascierto, I. Stanganelli, A. Cossu, 2009, BMC Cancer.

Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.

P. Ascierto, E. Simeone, F. Buonaguro, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)

F. Marincola, G. Botti, P. Ascierto, 2018, Journal of Translational Medicine.

The “Great Debate” at Melanoma Bridge 2020: December, 5th, 2020

V. Sondak, P. Ascierto, M. Atkins, 2021, Journal of translational medicine.

Intermediate dose recombinant interferon‐α as second‐line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon

P. Ascierto, G. Palmieri, G. Castello, 2000, Cancer.

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

G. Botti, P. Ascierto, I. Stanganelli, 2015, Journal of Translational Medicine.

BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.

G. Botti, P. Ascierto, R. Franco, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.

P. Ascierto, E. Simeone, M. Guida, 2007, European journal of cancer.

The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.

S. Mocellin, P. Quaglino, A. Maurichi, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials

D. Reintgen, Dale Han, M. Faries, 2018, Clinical & Experimental Metastasis.

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

V. Sondak, M. Ross, K. Shannon, 2022, Annals of Surgical Oncology.

Sentinel Node Biopsy in Thin and Thick Melanoma

G. Botti, A. Testori, S. Gandini, 2013, Annals of Surgical Oncology.

Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.

G. Botti, S. Lastoria, E. Celentano, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

G. Botti, A. Testori, A. Crispo, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma

M. Mihm, B. Hesse, R. Scolyer, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials

D. Reintgen, Dale Han, M. Faries, 2018, Clinical & Experimental Metastasis.

Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome

G. Botti, R. Franco, M. Cantile, 2010, Cancer biology & therapy.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

F. Fulciniti, G. Botti, P. Ascierto, 2014, Cancer Immunology, Immunotherapy.

Collagen sealant patch to reduce lymphatic drainage after lymph node dissection

A. Crispo, C. Caracò, N. Mozzillo, 2012, World Journal of Surgical Oncology.

Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis

P. Ascierto, E. Simeone, N. Mozzillo, 2017, Journal of Translational Medicine.

[The right inferior laryngeal nerve with a non-recurrent course].

M. G. Chiofalo, N. Mozzillo, U. Marone, 2003, Tumori.

[Morgagni-Larrey hernia: surgical treatment with Marlex. A case report].

G. Candela, L. Santini, C. Caracò, 1997, Minerva chirurgica.

Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.

P. Ascierto, A. Cossu, G. Palmieri, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel

P. Ascierto, P. Queirolo, A. D. Dei Tos, 2022, Journal for ImmunoTherapy of Cancer.

Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.

S. Mocellin, P. Quaglino, C. Rossi, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Update on PEG-interferon α-2b as adjuvant therapy in melanoma.

P. Ascierto, E. Simeone, G. Di Lorenzo, 2012, Anticancer research.

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment

F. Marincola, P. Ascierto, J. Kirkwood, 2010, Journal of Translational Medicine.

Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.

A. Faggiano, A. Colao, M. G. Chiofalo, 2008, Endocrine-related cancer.

Soluble interleukin-2 receptor in stage I-III melanoma.

G. Botti, P. Ascierto, R. Franco, 2006, Cytokine.

Electrochemotherapy in melanoma patients: a single institution experience.

G. Botti, P. Ascierto, E. Simeone, 2015, Melanoma management.

Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients

P. Ascierto, A. Cossu, G. Palmieri, 2020, Journal of clinical medicine.

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy)

G. Madonna, P. Ascierto, L. Zitvogel, 2022, Journal of Translational Medicine.

The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)

S. Staibano, M. Pizzichetta, I. Stanganelli, 2022, BMC cancer.

The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)

S. Staibano, M. Pizzichetta, I. Stanganelli, 2021, BMC Cancer.

Perspectives in melanoma: meeting report from the “Melanoma Bridge” (December 5th–7th, 2019, Naples, Italy)

J. Taube, R. Sullivan, P. Ascierto, 2020, Journal of Translational Medicine.

Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.

S. Mocellin, C. Rossi, A. Maurichi, 2014, JAMA surgery.

Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

P. Ascierto, E. Simeone, A. Cossu, 2006, BMC Cancer.

Prognostic V alue o f C irculating M elanoma C ells D etected b y Reverse T ranscriptase-Po lymerase C hain R eaction

P. Ascierto, A. Cossu, G. Palmieri, 2003 .

Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.

G. Botti, P. Ascierto, A. Cossu, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma

G. Botti, P. Ascierto, E. Simeone, 2014, Journal of Translational Medicine.

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis

G. Botti, P. Ascierto, E. Simeone, 2013, BMC Cancer.

Feasibility of neoadjuvant electrochemotherapy for a large metastatic lesion of the cheek in a patient with melanoma

G. Botti, P. Ascierto, L. Aloj, 2012 .

Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma

G. Botti, P. Ascierto, L. Aloj, 2012, Journal of Translational Medicine.

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience

P. Ascierto, V. de Giorgi, F. Grosso, 2021, Frontiers in Oncology.

Real Life Clinical Management and Survival in Cutaneous Malignant Melanoma: the Italian Clinical National Melanoma Registry (CNMR) Experience

P. Ascierto, V. de Giorgi, F. Grosso, 2020 .

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

G. Botti, P. Ascierto, M. Cantile, 2017, Journal of Translational Medicine.

The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019

P. Ascierto, H. Zarour, A. Testori, 2020, Journal of Translational Medicine.

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)

F. Marincola, G. Botti, P. Ascierto, 2019, Journal of Translational Medicine.

The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018

P. Ascierto, A. Testori, H. Tawbi, 2019, Journal of Translational Medicine.

Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study

S. Mocellin, P. Quaglino, C. Rossi, 2017, Annals of Surgical Oncology.

The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021

P. Ascierto, S. Demaria, H. Tawbi, 2022, Journal of translational medicine.

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors

G. Botti, P. Ascierto, A. Crispo, 2013, World Journal of Surgical Oncology.

Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach

G. Botti, P. Ascierto, P. Queirolo, 2019, Journal of Translational Medicine.

Vemurafenib beyond progression in a patient with metastatic melanoma: a case report

P. Ascierto, E. Simeone, P. Muto, 2015, Anti-cancer drugs.

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

G. Madonna, P. Ascierto, G. Ciliberto, 2015, Oncoimmunology.

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

P. Ascierto, G. Ciliberto, E. Simeone, 2014, Oncoimmunology.

Renal cell carcinoma with solitary toe metastasis

R. Autorino, S. Perdoná, Renato Franco, 2005, International journal of urology : official journal of the Japanese Urological Association.

Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study

P. Ascierto, G. Ferrara, K. Peris, 2023, Frontiers in Oncology.

Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)

P. Ascierto, V. de Giorgi, S. Mocellin, 2020, European Journal of Cancer.

Can High-Resolution Ultrasound Avoid the Sentinel Lymph-node Biopsy Procedure in the Staging Process of Patients with Stage I–II Cutaneous Melanoma?

G. Botti, A. Petrillo, O. Catalano, 2012, Ultraschall in der Medizin.

Surgical treatment of melanoma: from excision to sentinel node biopsy

C. Caracò, N. Mozzillo, C. Caracò, 2012 .

Resection in the popliteal fossa for metastatic melanoma

G. Botti, M. G. Chiofalo, N. Mozzillo, 2007, World journal of surgical oncology.

Detect ion of Occul t Melanoma Cel ls in Paraffin-Embedded Histo logica

G. Botti, P. Ascierto, A. Cossu, 2001 .

Safety and efficacy of electrochemotherapy in a series of patients with nonmetastasized primary or recurrent anorectal malignant melanoma.

P. Quaglino, M. Brizio, S. Carvalhal, 2020, Melanoma research.

Quality of Life Predictors in Patients With Melanoma: A Machine Learning Approach

E. Simeone, M. Pinto, A. de Sire, 2022, Frontiers in Oncology.

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

Gerardo Botti, Mariaelena Capone, Carmen Ballesteros-Merino, 2017, Oncoimmunology.

Sentinel lymph node biopsy does not change melanoma-specific survival among patients with breslow thickness greater than four millimeters

G. Botti, P. Ascierto, S. Lastoria, 2004, Annals of Surgical Oncology.

Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up.

G. Botti, P. Ascierto, M. G. Chiofalo, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Impact of False-Negative Sentinel Lymph Node Biopsy on Survival in Patients with Cutaneous Melanoma

G. Botti, E. Celentano, C. Caracò, 2007, Annals of Surgical Oncology.

Post-operative complications after completion thyroidectomy for differentiated thyroid cancer.

P. Delrio, N. Mozzillo, N. Losito, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Locoregional spread of cutaneous melanoma: sonography findings.

O. Catalano, N. Mozzillo, A. Siani, 2010, AJR. American journal of roentgenology.

Imaging Assessment of Interval Metastasis from Melanoma

P. Ascierto, R. Fusco, S. Setola, 2022, Journal of personalized medicine.

Previously Reported Sonographic Appearances of Regional Melanoma Metastases Are Not Likely Due to Necrosis

G. Botti, R. Franco, M. Petrillo, 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Sentinel Lymph Node Biopsy to Stage Patients with Cutaneous Melanoma at the National Cancer Institute of Naples. Results from 240 Sentinel Node Biopsies

G. Botti, P. Ascierto, S. Lastoria, 2002, Tumori.

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients

P. Ascierto, E. Simeone, D. Giannarelli, 2015, Journal of Immunotherapy for Cancer.

The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates

P. Ascierto, V. de Giorgi, M. Pizzichetta, 2020, BMC Cancer.

Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.

A. Gesierich, R. Dummer, R. Scolyer, 2022, JAMA surgery.

The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017

M. Ross, R. Sullivan, P. Ascierto, 2018, Journal of Translational Medicine.

Epithelioid cell-type melanoma as a prognostic factor of poor response to immunological treatment.

G. Botti, P. Ascierto, G. Castello, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

G. Madonna, D. Mallardo, P. Ascierto, 2018, Journal of Immunotherapy for Cancer.

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)

P. Ascierto, R. Dummer, G. Trinchieri, 2021, Journal of Translational Medicine.

Surgical Management of Sentinel Lymph Node Biopsy Outside Major Nodal Basin in Patients with Cutaneous Melanoma

G. Botti, S. Lastoria, L. Aloj, 2013, Annals of Surgical Oncology.

Therapeutic implications of sentinel lymph node biopsy in the staging of oral cancer

G. Botti, F. Ionna, S. Lastoria, 2004, Annals of Surgical Oncology.

Laparoscopic cholecystectomy for melanoma metastatic to the gallbladder: is it an adequate surgical procedure? Report of a case and review of the literature

M. G. Chiofalo, L. Pezzullo, C. Caracò, 2007, World journal of surgical oncology.

Sentinel node biopsy in head and neck cancer.

G. Botti, F. Ionna, S. Lastoria, 2001, Annals of surgical oncology.

Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma.

G. Botti, P. Ascierto, A. Cossu, 2016, The Journal of investigative dermatology.

Lymphoscintigraphy Defines New Lymphatic Pathways from Cutaneous Melanoma Site: Clinical Implications and Surgical Management

L. Aloj, C. Caracò, U. Marone, 2011, Radiology Research and Practice.

Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment

G. Botti, P. Ascierto, I. Stanganelli, 2019, Journal of translational medicine.

Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions

Antonio Daponte, Giuseppe Palmieri, Giuseppe Castello, 2000 .

Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions. The Melanoma Cooperative Study.

E Celentano, P. Ascierto, G. Castello, 2000, The British journal of dermatology.

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

C. Croce, L. Fattore, R. Mancini, 2017, Journal of Translational Medicine.

Sentinel lymph node biopsy in atypical Spitz nevi: is it useful?

G. Botti, S. Staibano, C. Caracò, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

I. Stanganelli, P. Queirolo, M. Mandalà, 2020, Diagnostic Pathology.

Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

F. Fulciniti, G. Botti, P. Ascierto, 2014, Cancer Immunology, Immunotherapy.

Immunological and biological changes during ipilimumab (Ipi) treatment and their correlation with clinical response and survival.

P. Ascierto, E. Simeone, P. Queirolo, 2012 .

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

G. Botti, P. Ascierto, E. Simeone, 2013, Journal of Translational Medicine.

[Hürthle cell neoplasms: diagnostic and therapeutic evaluations].

G. Conzo, L. Santini, A. Amore, 1998, Giornale di Chirurgia - Journal of Surgery.

Metastatic eccrine porocarcinoma: report of a case and review of the literature

M. G. Chiofalo, C. Caracò, N. Mozzillo, 2011, World journal of surgical oncology.

Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (Mal De Meleda)

G. Botti, F. Fazioli, C. Caracò, 2003, Journal of surgical oncology.

The role of spectrophotometry in the diagnosis of melanoma

Antonio Daponte, Fabrizio Ayala, Marco Palla, 2010, BMC dermatology.

Human Melanoma Metastases Express Functional CXCR4

G. Botti, P. Ascierto, R. Franco, 2006, Clinical Cancer Research.

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

G. Botti, P. Ascierto, V. de Giorgi, 2013, Journal of Translational Medicine.

A primary, lateral-cervical medullary thyroid carcinoma: a case report.

V. Colantuoni, G. De Rosa, G. Conzo, 1996, The Journal of clinical endocrinology and metabolism.

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial

F. Izzo, P. Delrio, G. Nasti, 2013, British Journal of Cancer.

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

G. Botti, P. Ascierto, I. Stanganelli, 2015, Journal of Translational Medicine.

The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022

A. Hauschild, P. Ascierto, J. Sosman, 2023, Journal of Translational Medicine.

Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

D. Mallardo, P. Ascierto, S. Warren, 2022, Journal for immunotherapy of cancer.

24 Nivolumab serum concentration in metastatic melanoma patients could be related to anti-tumor activity gene and outcome

G. Madonna, D. Mallardo, P. Ascierto, 2021, Journal for ImmunoTherapy of Cancer.

Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group.

Riccardo Bono, Alessandro Testori, Antonio Daponte, 2003, International journal of oncology.

Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach

G. Botti, P. Ascierto, A. Cossu, 2019, Journal of Translational Medicine.

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study

P. Ascierto, V. de Giorgi, I. Stanganelli, 2019, BMC Cancer.

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

G. Botti, P. Ascierto, M. Cantile, 2017, Journal of Translational Medicine.

The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019

P. Ascierto, H. Zarour, A. Testori, 2020, Journal of Translational Medicine.

Drainage in thyroid surgery: a prospective randomised clinical study.

M. G. Chiofalo, E. Celentano, N. Mozzillo, 2001, Chirurgia italiana.

2089805 Sentinel Lymph Node (SLN) Melanoma Micrometastasis Managed Conservatively: Sonography (US) Patterns Of Recurrence

A. Petrillo, O. Catalano, N. Mozzillo, 2015 .

The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017

M. Ross, R. Sullivan, P. Ascierto, 2018, Journal of Translational Medicine.

HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.

M. G. Chiofalo, G. Pirozzi, E. Celentano, 2004, Tissue antigens.

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)

F. Marincola, G. Botti, P. Ascierto, 2019, Journal of Translational Medicine.

Half forehead reconstruction with a single rotational scalp flap for dermatofibrosarcoma protuberans treatment

M. G. Chiofalo, C. Caracò, U. Marone, 2012, World Journal of Surgical Oncology.

Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma

G. Botti, P. Ascierto, L. Aloj, 2012, Journal of Translational Medicine.

A giant metastasis from follicular thyroid carcinoma.

P. Delrio, F. Ionna, C. Caracò, 1997, Journal of chemotherapy.

1105PVEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION.

Y. S. Kim, Su Jin Lee, J. Utikal, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)

P. Ascierto, B. Fox, J. Galon, 2023, Journal of Translational Medicine.

Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis

P. Ascierto, E. Simeone, N. Mozzillo, 2017, Journal of Translational Medicine.

European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma.

P. Ascierto, M. Mandalà, T. Mussack, 2023, The British journal of surgery.

[Differentiated thyroid cancer: prognostic factors].

G. Conzo, L. Santini, A. Giordano, 1999, Il Giornale di chirurgia.

fotemustine (FM) and dacarbazine (DTIC) versus DTIC ± interferon α in advanced malignant melanoma: A phase III study of the Southern Italy Cooperative Oncology Group (SICOG).

P. Ascierto, E. Simeone, M. G. Chiofalo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

D. Mallardo, P. Ascierto, E. Simeone, 2022, Journal of Translational Medicine.

Electrochemotherapy for rectal cancer after neoadjuvant radiotherapy: A case report

P. Delrio, N. Mozzillo, F. Ruffolo, 2014 .

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

G. Botti, P. Ascierto, E. Simeone, 2013, Journal of Translational Medicine.

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

G. Madonna, D. Mallardo, P. Ascierto, 2023, Journal of Translational Medicine.

Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.

G. Botti, P. Ascierto, A. Cossu, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunoscore: a new possible approach for melanoma classification

Fabrizio Ayala, Gerardo Botti, Mariaelena Capone, 2014, Journal of Immunotherapy for Cancer.

Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study

S. Mocellin, P. Quaglino, C. Rossi, 2017, Annals of Surgical Oncology.

World Journal of Surgical Oncology Open Access Resection in the Popliteal Fossa for Metastatic Melanoma

G. Botti, M. G. Chiofalo, N. Mozzillo, 2022 .

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study

G. Botti, P. Ascierto, V. de Giorgi, 2019, BMC Cancer.